Dissolving microneedles for nucleic acid delivery: A systematic search, review, and data synthesis.

Carmen I Tobos, Kim A Woodrow
{"title":"Dissolving microneedles for nucleic acid delivery: A systematic search, review, and data synthesis.","authors":"Carmen I Tobos, Kim A Woodrow","doi":"10.1016/j.actbio.2025.05.025","DOIUrl":null,"url":null,"abstract":"<p><p>Dissolving microneedles deliver many classes of nucleic acids, overcoming susceptibility to enzymatic cleavage and poor intracellular delivery. Understanding the impact of microneedle formulation on nucleic acid therapeutic efficacy is critical for clinical translation. Here, we performed a systematic search to identify preclinical dissolving microneedle studies that deliver nucleic acid therapeutics including aptamers, DNA enzymes, mRNA, miRNA, plasmid DNA, recombinant viral vectors, and siRNA. This review quantitatively synthesizes preclinical data to identify correlations between microneedle form and function. Factors such as polymer molecular weight and incorporation of a nucleic acid carrier strongly influence mechanical and biological properties, while other design parameters allow for more flexibility. Altogether, 83 % of studies show equivalent or superior efficacy to existing nucleic acid administration routes including topical, subcutaneous, and intramuscular administration. Data especially supports the use of dissolving microneedles for viral and cancer vaccine applications, with a growing body of work exploring their utility for gene silencing. Nonetheless, several knowledge gaps remain. Emerging nucleic acid carrier chemistries that retain efficacy with improved toxicity profiles will define the next generation of formulations. Plasmid DNA and viral vectors show excellent long-term stability in dissolving microneedles, but further characterization is needed for long RNA transcripts. Finally, future work could explore the potential for non-dermal administration routes, as well as co-delivery of nucleic acids with small molecules to leverage synergistic effects. STATEMENT OF SIGNIFICANCE: This review comprehensively, critically, and quantitatively synthesizes preclinical dissolving microneedles for nucleic acid delivery. This approach identifies empirically supported correlations between microneedle form and function, highlighting evidence-based best practices and remaining challenges. The form-function relationships identified in this review will be valuable to those within the immediate microneedle field, as well as more broadly to audiences interested in nucleic acid therapeutics, drug delivery systems, microfabrication, and delivery strategies for low resource settings.</p>","PeriodicalId":93848,"journal":{"name":"Acta biomaterialia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta biomaterialia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.actbio.2025.05.025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Dissolving microneedles deliver many classes of nucleic acids, overcoming susceptibility to enzymatic cleavage and poor intracellular delivery. Understanding the impact of microneedle formulation on nucleic acid therapeutic efficacy is critical for clinical translation. Here, we performed a systematic search to identify preclinical dissolving microneedle studies that deliver nucleic acid therapeutics including aptamers, DNA enzymes, mRNA, miRNA, plasmid DNA, recombinant viral vectors, and siRNA. This review quantitatively synthesizes preclinical data to identify correlations between microneedle form and function. Factors such as polymer molecular weight and incorporation of a nucleic acid carrier strongly influence mechanical and biological properties, while other design parameters allow for more flexibility. Altogether, 83 % of studies show equivalent or superior efficacy to existing nucleic acid administration routes including topical, subcutaneous, and intramuscular administration. Data especially supports the use of dissolving microneedles for viral and cancer vaccine applications, with a growing body of work exploring their utility for gene silencing. Nonetheless, several knowledge gaps remain. Emerging nucleic acid carrier chemistries that retain efficacy with improved toxicity profiles will define the next generation of formulations. Plasmid DNA and viral vectors show excellent long-term stability in dissolving microneedles, but further characterization is needed for long RNA transcripts. Finally, future work could explore the potential for non-dermal administration routes, as well as co-delivery of nucleic acids with small molecules to leverage synergistic effects. STATEMENT OF SIGNIFICANCE: This review comprehensively, critically, and quantitatively synthesizes preclinical dissolving microneedles for nucleic acid delivery. This approach identifies empirically supported correlations between microneedle form and function, highlighting evidence-based best practices and remaining challenges. The form-function relationships identified in this review will be valuable to those within the immediate microneedle field, as well as more broadly to audiences interested in nucleic acid therapeutics, drug delivery systems, microfabrication, and delivery strategies for low resource settings.

用于核酸递送的溶解微针:一个系统的搜索、回顾和数据综合。
溶解微针成功地递送了许多种类的核酸,克服了对酶裂解的敏感性和细胞内递送的不良。了解微针制剂对核酸治疗效果的影响对临床转化至关重要。在这里,我们进行了系统的搜索,以确定临床前溶解微针研究,提供核酸治疗,包括适体、DNA酶、mRNA、miRNA、质粒DNA、重组病毒载体和siRNA。这篇综述定量地综合了临床前数据,以确定微针形式和功能之间的相关性。聚合物分子量和核酸载体的掺入等因素强烈影响机械和生物特性,而其他设计参数允许更大的灵活性。总的来说,83%的研究显示与现有的核酸给药途径(包括局部给药、皮下给药和肌肉给药)相当或更好的疗效。数据尤其支持在病毒和癌症疫苗应用中使用溶解性微针,越来越多的工作正在探索它们在基因沉默方面的效用。尽管如此,仍存在一些知识空白。新兴的核酸载体化学,保留效力与改进的毒性概况将定义下一代配方。质粒DNA和病毒载体在溶解微针方面表现出优异的长期稳定性,但对于长链RNA转录物需要进一步的表征。最后,未来的工作可以探索非皮肤给药途径的潜力,以及与小分子核酸共同递送以利用协同效应。意义声明:溶解微针可输送多种临床批准的核酸(适配体、siRNA、mRNA)以及尚未达到临床翻译的核酸(DNAzymes、miRNA)。了解微针制剂对核酸治疗效果的影响对临床转化至关重要。本文综述了全面、批判性和定量地合成用于核酸递送的临床前溶解微针。该方法扩展了现有的叙述性评论,以确定经验支持的微针形式和功能之间的相关性,突出了基于证据的最佳实践和仍然存在的挑战。本综述中确定的形式-功能关系将对直接微针领域的研究人员以及对核酸治疗、药物输送系统、微制造和低资源环境下的输送策略感兴趣的更广泛的受众有价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信